-
3
-
-
0017807269
-
A hereditary molecular abnormality found in a patient with recurrent thrombosis
-
Aoki N, Moroi Y, Sakata Y, Yoshida N, Matsuda M. A hereditary molecular abnormality found in a patient with recurrent thrombosis. J Clin Invest 1978; 61: 1186-1195.
-
(1978)
J Clin Invest
, vol.61
, pp. 1186-1195
-
-
Aoki, N.1
Moroi, Y.2
Sakata, Y.3
Yoshida, N.4
Matsuda, M.5
-
4
-
-
0019471761
-
Abnormal plasminogen, a case of recurrent thrombosis
-
Kazama M, Tahara C, Suzuki Z, Gohchi K, Abe T. Abnormal plasminogen, a case of recurrent thrombosis. Thromb Res 1981; 21: 517-522.
-
(1981)
Thromb Res
, vol.21
, pp. 517-522
-
-
Kazama, M.1
Tahara, C.2
Suzuki, Z.3
Gohchi, K.4
Abe, T.5
-
5
-
-
0021081271
-
Plasminogen Paris I: Congenital abnormal plasminogen and its incidence in thrombosis
-
Soria J, Soria C, Bertrand O, Dunn F, Drouet L, Caen JP. Plasminogen Paris I: congenital abnormal plasminogen and its incidence in thrombosis. Thromb Res 1983; 32: 229-238.
-
(1983)
Thromb Res
, vol.32
, pp. 229-238
-
-
Soria, J.1
Soria, C.2
Bertrand, O.3
Dunn, F.4
Drouet, L.5
Caen, J.P.6
-
7
-
-
0021053614
-
Evidence for a rapid inhibitor to tissue plasminogen activator in plasma
-
Chmielewska J, Rånby M, Wiman B. Evidence for a rapid inhibitor to tissue plasminogen activator in plasma. Thromb Res 1983; 31: 427-436.
-
(1983)
Thromb Res
, vol.31
, pp. 427-436
-
-
Chmielewska, J.1
Rånby, M.2
Wiman, B.3
-
8
-
-
0021225478
-
Demonstration of a fast-acting inhibitor of plasminogen activators in human plasma
-
Kruithof EKO, Tran-Thang C, Ransijn A, Bachmann F. Demonstration of a fast-acting inhibitor of plasminogen activators in human plasma. Blood 1984; 64: 907-913.
-
(1984)
Blood
, vol.64
, pp. 907-913
-
-
Kruithof, E.K.O.1
Tran-Thang, C.2
Ransijn, A.3
Bachmann, F.4
-
9
-
-
0021214374
-
Evidence for the occurrence of a fast-acting inhibitor for tissue-type plasminogen activator in human plasma
-
Verheijen JH, Chang GTG, Kluft C. Evidence for the occurrence of a fast-acting inhibitor for tissue-type plasminogen activator in human plasma. Thromb Haemost 1984; 51: 392-395.
-
(1984)
Thromb Haemost
, vol.51
, pp. 392-395
-
-
Verheijen, J.H.1
Chang, G.T.G.2
Kluft, C.3
-
10
-
-
0021722255
-
Isolation of tissue-type plasminogen activator-inhibitor complexes from human plasma
-
Thorsen S, Philips M. Isolation of tissue-type plasminogen activator-inhibitor complexes from human plasma. Biochim Biophys Acta 1984; 802: 111-118.
-
(1984)
Biochim Biophys Acta
, vol.802
, pp. 111-118
-
-
Thorsen, S.1
Philips, M.2
-
11
-
-
0029805074
-
Fibrinolytic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris
-
Juhan-Vague I, Pyke S, Alessi M, Jespersen J, Haverkate F, Thompson S. Fibrinolytic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. Circulation 1996; 94: 2057-2063.
-
(1996)
Circulation
, vol.94
, pp. 2057-2063
-
-
Juhan-Vague, I.1
Pyke, S.2
Alessi, M.3
Jespersen, J.4
Haverkate, F.5
Thompson, S.6
-
12
-
-
0024558517
-
Bleeding diathesis due to decreased functional activity of type 1 plasminogen activator inhibitor
-
Schleef RR, Higgins DL, Pillemer E, Levitt LJ. Bleeding diathesis due to decreased functional activity of type 1 plasminogen activator inhibitor. J Clin Invest 1989; 83: 1747-1752.
-
(1989)
J Clin Invest
, vol.83
, pp. 1747-1752
-
-
Schleef, R.R.1
Higgins, D.L.2
Pillemer, E.3
Levitt, L.J.4
-
13
-
-
0025971596
-
A lifelong bleeding disorder associated with a deficiency of plasminogen activator inhibitor Type 1
-
Diéval J, Nguyen G, Gross S, Delobel J, Kruithof EKO. A lifelong bleeding disorder associated with a deficiency of plasminogen activator inhibitor Type 1. Blood 1991; 77: 528-532.
-
(1991)
Blood
, vol.77
, pp. 528-532
-
-
Diéval, J.1
Nguyen, G.2
Gross, S.3
Delobel, J.4
Kruithof, E.K.O.5
-
14
-
-
0026448949
-
Complete deficiency of plasminogen-activator inhibitor type 1 due to a frame-shift mutation
-
Fay WP, Shapiro AD, Shih JL, Schleef RR, Ginsburg D. Complete deficiency of plasminogen-activator inhibitor type 1 due to a frame-shift mutation. N Engl J Med 1992; 327: 1729-1733.
-
(1992)
N Engl J Med
, vol.327
, pp. 1729-1733
-
-
Fay, W.P.1
Shapiro, A.D.2
Shih, J.L.3
Schleef, R.R.4
Ginsburg, D.5
-
15
-
-
0029827894
-
Targeted gene manipulation and transfer of the plasminogen and coagulation systems in mice
-
Carmeliet P, Collen D. Targeted gene manipulation and transfer of the plasminogen and coagulation systems in mice. Fibrinolysis 1996; 10: 195-213.
-
(1996)
Fibrinolysis
, vol.10
, pp. 195-213
-
-
Carmeliet, P.1
Collen, D.2
-
16
-
-
0020264575
-
A sensitive assay for tissue plasminogen activator
-
Rånby M, Norrman B, Wallén P. A sensitive assay for tissue plasminogen activator. Thromb Res 1982; 27: 743-749.
-
(1982)
Thromb Res
, vol.27
, pp. 743-749
-
-
Rånby, M.1
Norrman, B.2
Wallén, P.3
-
17
-
-
0020359280
-
A simple, sensitive spectrophotometric assay for extrinsic (tissue-type) plasminogen activator applicable to measurements in plasma
-
Verheijen JH, Mullart E, Chang GTG, Kluft C, Wijngaards G. A simple, sensitive spectrophotometric assay for extrinsic (tissue-type) plasminogen activator applicable to measurements in plasma. Thromb Haemost 1982; 48: 266-269.
-
(1982)
Thromb Haemost
, vol.48
, pp. 266-269
-
-
Verheijen, J.H.1
Mullart, E.2
Chang, G.T.G.3
Kluft, C.4
Wijngaards, G.5
-
18
-
-
0021207023
-
A sensitive assay for tissue plasminogen activator activity in plasma using adsorption on lysine Sepharose
-
Gyzander E, Eriksson E, Teger-Nilsson A-C. A sensitive assay for tissue plasminogen activator activity in plasma using adsorption on lysine Sepharose. Thromb Res 1984; 35: 547-558.
-
(1984)
Thromb Res
, vol.35
, pp. 547-558
-
-
Gyzander, E.1
Eriksson, E.2
Teger-Nilsson, A.-C.3
-
19
-
-
0000634859
-
A new kit for determination of tissue plasminogen activator and its inhibitor in blood
-
Nilsson K, Rosén S, Friberger P. A new kit for determination of tissue plasminogen activator and its inhibitor in blood. Fibrinolysis 1987; 1: 163-168.
-
(1987)
Fibrinolysis
, vol.1
, pp. 163-168
-
-
Nilsson, K.1
Rosén, S.2
Friberger, P.3
-
20
-
-
0021885521
-
Bioimmunoassay (BIA) of tissue plasminogen activator (t-PA) and its specific inhibitor (t-PA/INH)
-
Mahmoud M, Gaffney PJ. Bioimmunoassay (BIA) of tissue plasminogen activator (t-PA) and its specific inhibitor (t-PA/INH) Thromb Haemost 1985; 53: 356-359.
-
(1985)
Thromb Haemost
, vol.53
, pp. 356-359
-
-
Mahmoud, M.1
Gaffney, P.J.2
-
21
-
-
0024443860
-
Sensitive and direct assays for functionally active plasminogen activators (tissue-type and urokinase-type) in plasma
-
Mahmoud-Alexandroni M, Heath AB, Gaffney PJ. Sensitive and direct assays for functionally active plasminogen activators (tissue-type and urokinase-type) in plasma. Am J Clin Pathol 1989; 92: 308-314.
-
(1989)
Am J Clin Pathol
, vol.92
, pp. 308-314
-
-
Mahmoud-Alexandroni, M.1
Heath, A.B.2
Gaffney, P.J.3
-
22
-
-
0026712775
-
Bioimmunoassay for tissue-type plasminogen activator (t-PA) in human plasma: Evaluation of blood sampling and handling procedures and comparison with other t-PA activity methods
-
Meijer P, Boon R, Jie AFH, Rosén S, Kluft C. Bioimmunoassay for tissue-type plasminogen activator (t-PA) in human plasma: Evaluation of blood sampling and handling procedures and comparison with other t-PA activity methods. Fibrinolysis 1992; 6 (supp 3): 97-99.
-
(1992)
Fibrinolysis
, vol.6
, Issue.3 SUPPL.
, pp. 97-99
-
-
Meijer, P.1
Boon, R.2
Afh, J.3
Rosén, S.4
Kluft, C.5
-
23
-
-
33749767012
-
Functional measurement of t-PA in plasma using a bead immuno chromogenic assay (BICA)
-
Dahl KH, Klokk Holst J, Smith P, Gogstad GO. Functional measurement of t-PA in plasma using a bead immuno chromogenic assay (BICA). Fibrinolysis 1987; 1: 83-89.
-
(1987)
Fibrinolysis
, vol.1
, pp. 83-89
-
-
Dahl, K.H.1
Klokk Holst, J.2
Smith, P.3
Gogstad, G.O.4
-
24
-
-
0029963427
-
Blood collection and handling procedures for assessment of plasminogen activators and inhibitors (Leiden Fibrinolysis Workshop)
-
Kluft C, Verheijen JH. Blood collection and handling procedures for assessment of plasminogen activators and inhibitors (Leiden Fibrinolysis Workshop). Fibrinolysis 1996; 10 (supp 2): 171-179.
-
(1996)
Fibrinolysis
, vol.10
, Issue.2 SUPPL.
, pp. 171-179
-
-
Kluft, C.1
Verheijen, J.H.2
-
25
-
-
0022525897
-
Interleukin 1 and lipoplysaccharide induce an inhibitor of tissue-type plasminogen activator in vivo and in cultured endothelial cells
-
Emeis JJ, Kooistra T. Interleukin 1 and lipoplysaccharide induce an inhibitor of tissue-type plasminogen activator in vivo and in cultured endothelial cells. J Exp Med 1986; 163: 1260-1266.
-
(1986)
J Exp Med
, vol.163
, pp. 1260-1266
-
-
Emeis, J.J.1
Kooistra, T.2
-
26
-
-
0019199051
-
Euglobulin clot lysis time, a rapid and sensitive method for the assay of fibrinolytic activity after venous stasis
-
Nordby E, Arnesen H, Andersson P, Godal H. Euglobulin clot lysis time, a rapid and sensitive method for the assay of fibrinolytic activity after venous stasis. Scand J Haematol 1980; 25:407-411.
-
(1980)
Scand J Haematol
, vol.25
, pp. 407-411
-
-
Nordby, E.1
Arnesen, H.2
Andersson, P.3
Godal, H.4
-
27
-
-
0027938783
-
New aspects of blood collection and handling procedures for the assessment of t-PA and PAI-1 variables after the introduction of acid blood collection
-
Meijer P, Kret R, Bloetjes PTM, Rosén S, Kluft C. New aspects of blood collection and handling procedures for the assessment of t-PA and PAI-1 variables after the introduction of acid blood collection. Fibrinolysis 1994; 8 (supp 2): 145-147
-
(1994)
Fibrinolysis
, vol.8
, Issue.2 SUPPL.
, pp. 145-147
-
-
Meijer, P.1
Kret, R.2
Bloetjes, P.T.M.3
Rosén, S.4
Kluft, C.5
-
28
-
-
0028278065
-
Fibrinolytic activity and arterial disease
-
Meade TW, Howarth DJ, Cooper J. Fibrinolytic activity and arterial disease. Lancet 1994; 343: 1442.
-
(1994)
Lancet
, vol.343
, pp. 1442
-
-
Meade, T.W.1
Howarth, D.J.2
Cooper, J.3
-
29
-
-
0027360661
-
Predictive value of tissue plasminogen activator mass concentration on long-term mortality in patients with coronary artery disease
-
Jansson JH, Olofsson BO, Nilsson TK. Predictive value of tissue plasminogen activator mass concentration on long-term mortality in patients with coronary artery disease. A 7-year follow-up. Circulation 1993; 88: 2030-2034.
-
(1993)
A 7-year Follow-up. Circulation
, vol.88
, pp. 2030-2034
-
-
Jansson, J.H.1
Olofsson, B.O.2
Nilsson, T.K.3
-
31
-
-
0027274074
-
Endogenous tissue-type plasminogen activator and risk of myocardial infarction
-
Ridker PM, Vaughan DE, Stampfer MJ. Endogenous tissue-type plasminogen activator and risk of myocardial infarction. Lancet 1994; 341: 1165-1168.
-
(1994)
Lancet
, vol.341
, pp. 1165-1168
-
-
Ridker, P.M.1
De Vaughan2
Stampfer, M.J.3
-
32
-
-
0025276746
-
A depression of active tissue plasminogen activator in plasma characterizes patients with unstable angina pectoris who develop myocardial infarction
-
Munkvad S, Gram J, Jespersen J. A depression of active tissue plasminogen activator in plasma characterizes patients with unstable angina pectoris who develop myocardial infarction. Eur Heartl 1990; 11: 525-528.
-
(1990)
Eur Heartl
, vol.11
, pp. 525-528
-
-
Munkvad, S.1
Gram, J.2
Jespersen, J.3
-
33
-
-
0028832052
-
Association of fibrinolytic parameters with early atherosclerosis
-
The ARIC study
-
Salomaa V, Stinson V, Kark JD, Folsom AR, Davis CE, Wu K. Association of fibrinolytic parameters with early atherosclerosis. The ARIC study. Circulation 1995; 91: 284-290.
-
(1995)
Circulation
, vol.91
, pp. 284-290
-
-
Salomaa, V.1
Stinson, V.2
Kark, J.D.3
Folsom, A.R.4
Davis, C.E.5
Wu, K.6
-
34
-
-
0030664330
-
The increase of plasminogen activator inhibitor activity is associated with graft occlusion in patients undergoing aorto-coronary bypass surgery
-
Rifón J, Páramo JA, Panizo C, Montes R, Rocha E. The increase of plasminogen activator inhibitor activity is associated with graft occlusion in patients undergoing aorto-coronary bypass surgery. Br J Haematol 1997; 99: 262-267.
-
(1997)
Br J Haematol
, vol.99
, pp. 262-267
-
-
Rifón, J.1
Páramo, J.A.2
Panizo, C.3
Montes, R.4
Rocha, E.5
-
35
-
-
0028226514
-
Prospective study of endogenous tissue plasminogen activator and stroke
-
Ridker PM, Hennekens CH, Stampfer MJ. Prospective study of endogenous tissue plasminogen activator and stroke. Lancet 1994; 343: 940-942.
-
(1994)
Lancet
, vol.343
, pp. 940-942
-
-
Ridker, P.M.1
Ch, H.2
Stampfer, M.J.3
-
36
-
-
0027944013
-
Abnormally high circulation levels of tissue plasminogen activator and plasminogen activator inhibitor-1 in patients with a history of ischemic stroke
-
Margaglione M, Di Minno G, Grandone E et al. Abnormally high circulation levels of tissue plasminogen activator and plasminogen activator inhibitor-1 in patients with a history of ischemic stroke. Arterioscler Thromb 1994; 14: 1741-1745.
-
(1994)
Arterioscler Thromb
, vol.14
, pp. 1741-1745
-
-
Margaglione, M.1
Di Minno, G.2
Grandone, E.3
-
37
-
-
0028909230
-
Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris
-
Thompson SG, Kienast J, Pyke SDM, Haverkate F, van de Loo JCW. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. New Engl J Med 1995; 332: 635-641.
-
(1995)
New Engl J Med
, vol.332
, pp. 635-641
-
-
Thompson, S.G.1
Kienast, J.2
Pyke, S.D.M.3
Haverkate, F.4
Van De Loo, J.C.W.5
-
38
-
-
0028043319
-
Constitutive synthesis of tissue-type plasminogen activator (t-PA) and plasminogen activator inhibitor type 1 (PAI-1): Conditions and therapeutic targets
-
Kluft C. Constitutive synthesis of tissue-type plasminogen activator (t-PA) and plasminogen activator inhibitor type 1 (PAI-1): conditions and therapeutic targets. Fibrinolysis 1994; 8(supp 2): 1-7
-
(1994)
Fibrinolysis
, vol.8
, Issue.2 SUPPL.
, pp. 1-7
-
-
Kluft, C.1
-
39
-
-
0028148930
-
A bio-immuno assay to determine free tissue-type plasminogen activator (t-PA) in Stabilyte® plasma
-
Bos R, Revet M, Niewenhuizen W. A bio-immuno assay to determine free tissue-type plasminogen activator (t-PA) in Stabilyte® plasma. Fibrinolysis 1994; 8(supp 2): 163-165.
-
(1994)
Fibrinolysis
, vol.8
, Issue.2 SUPPL.
, pp. 163-165
-
-
Bos, R.1
Revet, M.2
Niewenhuizen, W.3
-
40
-
-
33749776813
-
A bio-functional immunoassay, BIA, for tissue plasminogen activator, tPA
-
April
-
Rånby M, Johansson G. A bio-functional immunoassay, BIA, for tissue plasminogen activator, tPA. Leiden Workshop on Fibrinolysis, April 1994.
-
(1994)
Leiden Workshop on Fibrinolysis
-
-
Johansson G, R.M.1
-
41
-
-
0026045883
-
Circadian variation of fibrinolytic activity in blood
-
Andreotti F, Kluft C. Circadian variation of fibrinolytic activity in blood. Chronobiology Int 1991; 8: 336-351.
-
(1991)
Chronobiology Int
, vol.8
, pp. 336-351
-
-
Andreotti, F.1
Kluft, C.2
-
42
-
-
0031457896
-
Dietary fish oil (4 g daily) and cardiovascular risk markers in healthy men
-
Marckmann P, Bladbjerg E, Jespersen J. Dietary fish oil (4 g daily) and cardiovascular risk markers in healthy men. Arterioscler Thromb Vase Biol 1997; 17: 3384-3391.
-
(1997)
Arterioscler Thromb Vase Biol
, vol.17
, pp. 3384-3391
-
-
Marckmann, P.1
Bladbjerg, E.2
Jespersen, J.3
-
43
-
-
0027739335
-
Effect of isotretinoin on endogenous tissue-type plasminogen activator (t-PA) and plasmonogen activator inhibitor 1 (PAI-1) in human plasma
-
Wallnofer AE, van Griensven JM, Schoemaker HC et al. Effect of isotretinoin on endogenous tissue-type plasminogen activator (t-PA) and plasmonogen activator inhibitor 1 (PAI-1) in human plasma. Thromb Haemost 1993; 70: 1005-1008.
-
(1993)
Thromb Haemost
, vol.70
, pp. 1005-1008
-
-
Wallnofer, A.E.1
Van Griensven, J.M.2
Schoemaker, H.C.3
-
44
-
-
0027383217
-
Influence of gender, age and sampling time on plasma fibrinolytic variables and fibrinogen
-
Eliasson M, Evrin P-E, Lundblad D, Asplund K, Rånby M. Influence of gender, age and sampling time on plasma fibrinolytic variables and fibrinogen. Fibrinolysis 1993; 7: 316-323.
-
(1993)
Fibrinolysis
, vol.7
, pp. 316-323
-
-
Eliasson, M.1
Evrin, P.-E.2
Lundblad, D.3
Asplund, K.4
Rånby, M.5
|